ReviewCurrent gastroenterology reports2025
Hepatology in the Digital Era: A Review of Telehealth Care for Liver Disease.
Review in Current gastroenterology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessing Acceptance and Intention to Use of Home Telemonitoring Among Patients with Liver Cirrhosis: Development and Initial Psychometric Validation of a TAM-Based Questionnaire.Diagnostics (Basel, Switzerland) · 2026Article
- Predictors of Missed Appointments in Digestive Health: A Comparative Analysis of Telehealth and In-Person Visits.Clinical and translational gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTelehealth has become an integral component of healthcare delivery in the US. While telehealth has been utilized within Hepatology for decades for HCV through Project ECHO and adapted by the VA, the COVID-19 pandemic catalyzed an unprecedented expansion of telehealth. This review examines the evolution, benefits, challenges, and future implications of telehealth in Hepatology. RECENT
findingsTelehealth can improve access to care for underserved patient populations and provide continuity of care for chronic liver disease and liver transplant patients. Studies suggest that telehealth can deliver equivalent quality of care to in-person visits with high satisfaction rates among patients and providers. However, there are barriers to telehealth including disparities in technology access, limitations in quality of virtual encounters, and limited insurance policies. However, many questions remain. As Hepatology enters the digital era, telehealth holds promise for enhancing care delivery, but its integration must be guided by evidence-based practices.
Indexed as
Identifiers
40153166What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.